Tiago Fauth
Stock Analyst at Raymond James
(4.40)
# 1,240
Out of 5,023 analysts
302
Total ratings
45.9%
Success rate
10.7%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $60 | $28.13 | +113.30% | 1 | Oct 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $46 | $18.38 | +150.27% | 1 | Sep 25, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | n/a | $32.17 | - | 3 | Sep 23, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $87 → $84 | $43.54 | +92.93% | 3 | Sep 8, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $945 | $295.51 | +219.79% | 3 | Aug 17, 2026 | |
| PLYX Polaryx Therapeutics | Initiated Coverage: Buy | $6 | $2.08 | +188.46% | 1 | Aug 13, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $26 → $27 | $8.91 | +203.03% | 2 | Aug 10, 2026 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $46 | $9.82 | +368.43% | 1 | Jun 25, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $76 → $98 | $67.25 | +45.72% | 18 | Jun 17, 2026 | |
| INSM Insmed | Reiterated: Buy | $200 → $185 | $111.12 | +66.49% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $95 | $63.46 | +49.70% | 22 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 → $239 | $235.67 | +1.41% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.8097 | +641.02% | 1 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $414 → $700 | $541.70 | +29.22% | 26 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $11.36 | +76.06% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $3.80 | +84.21% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $3.78 | n/a | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $31 | $28.64 | n/a | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $22.54 | n/a | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $333 → $395 | $219.72 | n/a | 13 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $65 | $15.22 | n/a | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $4.81 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $64.51 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $1.04 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $10.28 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $14.12 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $227.87 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $57.18 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $19.40 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $45.71 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $10.65 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $28 | $13.74 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $1.72 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $34 | $1.22 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $20.65 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.87 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $2.62 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $14 | $2.14 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $11.07 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $340 → $319 | $919.21 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $33.62 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $259 | $403.04 | n/a | 2 | Apr 28, 2021 |
Avalyn Pharma
Oct 2, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $28.13
Upside: +113.30%
Seaport Therapeutics
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $18.38
Upside: +150.27%
Rapport Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $32.17
Upside: -
Ionis Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $87 → $84
Current: $43.54
Upside: +92.93%
Praxis Precision Medicines
Aug 17, 2026
Reiterated: Buy
Price Target: $945
Current: $295.51
Upside: +219.79%
Polaryx Therapeutics
Aug 13, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.08
Upside: +188.46%
Tonix Pharmaceuticals Holding
Aug 10, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $8.91
Upside: +203.03%
MapLight Therapeutics
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $9.82
Upside: +368.43%
BridgeBio Pharma
Jun 17, 2026
Reiterated: Buy
Price Target: $76 → $98
Current: $67.25
Upside: +45.72%
Insmed
May 8, 2026
Reiterated: Buy
Price Target: $200 → $185
Current: $111.12
Upside: +66.49%
May 8, 2026
Reiterated: Buy
Price Target: $108 → $95
Current: $63.46
Upside: +49.70%
May 6, 2026
Reiterated: Buy
Price Target: $227 → $239
Current: $235.67
Upside: +1.41%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $0.8097
Upside: +641.02%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $414 → $700
Current: $541.70
Upside: +29.22%
Mar 5, 2026
Reiterated: Buy
Price Target: $26 → $20
Current: $11.36
Upside: +76.06%
Feb 27, 2026
Reiterated: Buy
Price Target: $10 → $7
Current: $3.80
Upside: +84.21%
Sep 4, 2025
Reiterated: Buy
Price Target: $21 → $18
Current: $3.78
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $25 → $31
Current: $28.64
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $101
Current: $22.54
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: $333 → $395
Current: $219.72
Upside: n/a
Jul 9, 2025
Reiterated: Buy
Price Target: $88 → $65
Current: $15.22
Upside: n/a
May 28, 2025
Reiterated: Buy
Price Target: $8 → $7
Current: $4.81
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: $91
Current: $64.51
Upside: n/a
Mar 4, 2025
Reiterated: Hold
Price Target: $4 → $3
Current: $1.04
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $10.28
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $14.12
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $227.87
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $57.18
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $19.40
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $45.71
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $10.65
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $34 → $28
Current: $13.74
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $1.72
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $38 → $34
Current: $1.22
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $20.65
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $4.87
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $2.62
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $19 → $14
Current: $2.14
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $28 → $14
Current: $11.07
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $340 → $319
Current: $919.21
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $33.62
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $265 → $259
Current: $403.04
Upside: n/a